Dimensional Fund Advisors’s CorMedix CRMD Stock Holding History

Dimensional Fund Advisors’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-21,601	Closed	-$93.5K	–	3360
2024 Q2	$93.5K	Hold	21,601	–	–	﹤0.01%	3258
2024 Q1	$91.6K	Hold	21,601	–	–	﹤0.01%	3267
2023 Q4	$81.2K	Hold	21,601	–	–	﹤0.01%	3298
2023 Q3	$79.9K	Hold	21,601	–	–	﹤0.01%	3340
2023 Q2	$85.6K	Hold	21,601	–	–	﹤0.01%	3347
2023 Q1	$89.4K	Buy	+21,601	New	+$88.4K	﹤0.01%	3319
2022 Q3	$61K	Sell	21,585 -9,406	-30%	-$39.1K	﹤0.01%	3382
2022 Q2	$125K	Buy	30,991 +13,088	+73%	+$48.6K	﹤0.01%	3303
2022 Q1	$98K	Hold	17,903	–	–	﹤0.01%	3395
2021 Q4	$81K	Buy	+17,903	New	+$88.9K	﹤0.01%	3455
2016 Q3	–	Sell	-2,052	Closed	-$20K	–	3278
2016 Q2	$20K	Hold	2,052	–	–	﹤0.01%	3282
2016 Q1	$27K	Hold	2,052	–	–	﹤0.01%	3281
2015 Q4	$21K	Sell	2,052 -588	-22%	-$6.77K	﹤0.01%	3320
2015 Q3	$26K	Sell	2,640 -309	-10%	-$4.76K	﹤0.01%	3354
2015 Q2	$57K	Buy	+2,949	New	+$101K	﹤0.01%	3332

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EIM

Elliott Investment Management West Palm Beach, Florida $22.7B AUM 59.88% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors's CRMD Position: Q3 2024 in Review

Dimensional Fund Advisors sold out of CorMedix (CRMD) in Q3 2024, closing a stake of 21,601 shares — an estimated $93.5K sold.

Dimensional Fund Advisors first reported a position in CRMD in Q2 2015 and held it in 15 quarters. The position peaked at $125K in Q2 2022. 102 funds tracked by Wall St. Rank hold CRMD as of Q3 2024.

Dimensional Fund Advisors reported no remaining CorMedix position as of Q3 2024 after selling out during the quarter.
Dimensional Fund Advisors sold 21,601 CorMedix shares in Q3 2024, an estimated $93.5K.
Dimensional Fund Advisors first reported a position in CorMedix in Q2 2015 and held it in 15 quarters.
Dimensional Fund Advisors's CorMedix position peaked at $125K in Q2 2022.
102 funds tracked by Wall St. Rank held CorMedix as of Q3 2024.

Based on Dimensional Fund Advisors's 13F filing for Q3 2024, filed 7 Nov 2024.